Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: A prospective phase II study-Reference-Cited by-同舟云学术

Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: A prospective phase II study

Published:2012-11 Issue:2 Volume:105 Page:161-166
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Mantini Giovanna,Valentini Vincenzo,Meduri Bruno,Margaritora Stefano,Balducci Mario,Micciché Francesco,Nardone Luigia,De Rose Fiorenza,Cesario Alfredo,Larici Anna Rita,Maggi Fabio,Calcagni Maria Lucia,Granone Pierluigi

Publisher

Elsevier BV

Subject

Radiology, Nuclear Medicine and imaging,Oncology,Hematology

Reference47 articles.

1. Cancer burden for the year 2000: the global picture;Parkin;Eur J Cancer,2001

2. Phase III study comparing cisplatin plus gemcitabine with cisplatin plus pemetrexed in chemotherapy-naïve patients with advanced-stage non-small-cell lung cancer;Scagliotti;J Clin Oncol,2008

3. Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomized clinical trials;Non-Small Cell Lung Cancer Collaborative Group;BMJ,1995

4. Polychemotherapy in advanced non small cell lung cancer: a meta-analysis;Souquet;Lancet,1993

5. Chemotherapy for advanced non-small cell lung cancer: how much benefit is enough?;Grilli;J Clin Oncol,1993

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of frequent whole-body CT scans during immune checkpoint inhibitor (ICI) therapy on antitumor immune efficacy;2024-06-07

2. Low‐dose radiation therapy mobilizes antitumor immunity: New findings and future perspectives;International Journal of Cancer;2023-12-07

3. Opportunities and challenges in combining immunotherapy and radiotherapy in esophageal cancer;Journal of Cancer Research and Clinical Oncology;2023-11-20

4. Exploring low-dose radiotherapy to overcome radio-immunotherapy resistance;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2023-10

5. Update of latest data for combined therapy for esophageal cancer using radiotherapy and immunotherapy: A focus on efficacy, safety, and biomarkers;Chinese Journal of Cancer Research;2023